·
4 MIN READ

AMA in the News: February 2023

Read media highlights mentioning the American Medical Association for February 2023.

series
AMA in the News
AMA in the News
·
13 MIN READ

Feb. 24, 2023: National Advocacy Update

FDA advisory panels vote 19-0 in favor of OTC naloxone and more in the latest National Advocacy Update.

Advocacy Update
·
8 MIN READ

Feb. 24, 2023: State Advocacy Update

Georgia medical board updates licensing application to support physician wellness and more in the latest State Advocacy Update.

Advocacy Update
·
2 MIN READ

AMA: FDA panels’ naloxone recommendation will save lives

Two advisory committees voted today to recommend to the FDA that naloxone, the overdose-reversing drug, be available over the counter.

Press Releases
·
3 MIN READ

AMA honors Director of National Drug Control Policy with award

Dr. Gupta is the first physician to serve as Director of National Drug Control Policy and lead the White House Office of National Drug Control Policy (ONDCP).

Press Releases
·
3 MIN READ

AMA presents Government Service Award to CDC official

Dr. Houry has participated on numerous public health boards and committees.

Press Releases
·
10 MIN READ

Feb. 10, 2023: National Advocacy Update

COVID-19 public health emergency set to end May 11 with important implications for patients and physicians and more in the latest National Advocacy Update.

Advocacy Update
·
2 MIN READ

Jan. 27, 2023: Advocacy Update spotlight on buprenorphine prescribing

Buprenorphine prescribing now available to all DEA-registered physicians and more in the latest Advocacy Update spotlight.

Advocacy Update
·
4 MIN READ

Jan. 27, 2023: State Advocacy Update

Recap of the 2023 AMA State Advocacy Summit and more in the latest State Advocacy Update.

Advocacy Update